492 related articles for article (PubMed ID: 29198002)
21. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
Åkerberg D; Ansari D; Andersson R
World J Gastroenterol; 2016 Jul; 22(28):6424-33. PubMed ID: 27605878
[TBL] [Abstract][Full Text] [Related]
22. A patient-centered, multidisciplinary approach to treating borderline resectable pancreatic adenocarcinoma.
Hester CA; Katz MHG
Chin Clin Oncol; 2022 Dec; 11(6):45. PubMed ID: 36509553
[TBL] [Abstract][Full Text] [Related]
23. Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot.
Pilgrim CHC; Maciejewska A; Ayres N; Ellis S; Goodwin M; Zalcberg JR; Haydon A
ANZ J Surg; 2022 Oct; 92(10):2565-2570. PubMed ID: 36054233
[TBL] [Abstract][Full Text] [Related]
24. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
25. Imaging for pancreatic ductal adenocarcinoma.
Horvat N; Ryan DE; LaGratta MD; Shah PM; Do RK
Chin Clin Oncol; 2017 Dec; 6(6):62. PubMed ID: 29307202
[TBL] [Abstract][Full Text] [Related]
26. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
[TBL] [Abstract][Full Text] [Related]
27. Extrapancreatic perineural invasion in pancreatic adenocarcinoma.
Patel BN; Olcott E; Jeffrey RB
Abdom Radiol (NY); 2018 Feb; 43(2):323-331. PubMed ID: 28980054
[TBL] [Abstract][Full Text] [Related]
28. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
Bowman AW; Bolan CW
Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
[TBL] [Abstract][Full Text] [Related]
29. "Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer.
Lombardi P; Silvestri S; Marino D; Santarelli M; Campra D; De Paolis P; Aglietta M; Leone F;
Crit Rev Oncol Hematol; 2019 Jan; 133():17-24. PubMed ID: 30661653
[TBL] [Abstract][Full Text] [Related]
30. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.
Kato Y; Yamada S; Tashiro M; Sonohara F; Takami H; Hayashi M; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kodera Y
HPB (Oxford); 2019 Sep; 21(9):1211-1218. PubMed ID: 30773450
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma.
Suto H; Oshima M; Ando Y; Matsukawa H; Takahashi S; Shibata T; Kamada H; Kobara H; Masaki T; Kumamoto K; Suzuki Y; Okano K
HPB (Oxford); 2023 Jan; 25(1):136-145. PubMed ID: 36307256
[TBL] [Abstract][Full Text] [Related]
32. Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.
Liu X; Fu Y; Chen Q; Wu J; Gao W; Jiang K; Miao Y; Wei J
BMC Gastroenterol; 2018 Nov; 18(1):168. PubMed ID: 30400836
[TBL] [Abstract][Full Text] [Related]
33. Radiologic evaluation of patients undergoing the modified Appleby procedure for locally advanced pancreatic neoplasms: a case series.
Vergauwen MAT; Perillo M; Garces-Descovich A; Barrows CE; Moser AJ; Mortelé KJ
Abdom Radiol (NY); 2018 Feb; 43(2):467-475. PubMed ID: 29022090
[TBL] [Abstract][Full Text] [Related]
34. [Radiological evaluation of pancreatic ductal adenocarcinoma].
Akai H; Otomo K
Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
[TBL] [Abstract][Full Text] [Related]
35. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic Adenocarcinoma: Diagnostic Errors, Contributing Factors and Solutions.
Budigi B; Oliphant M; Itri J
Acad Radiol; 2022 Jul; 29(7):967-976. PubMed ID: 34838452
[TBL] [Abstract][Full Text] [Related]
37. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
38. Surgery for pancreatic cancer: critical radiologic findings for clinical decision making.
Fonseca AL; Fleming JB
Abdom Radiol (NY); 2018 Feb; 43(2):374-382. PubMed ID: 28948329
[TBL] [Abstract][Full Text] [Related]
39. Preoperative defining system for pancreatic head cancer considering surgical resection.
Yang SJ; Hwang HK; Kang CM; Lee WJ
World J Gastroenterol; 2016 Jul; 22(26):6076-82. PubMed ID: 27468199
[TBL] [Abstract][Full Text] [Related]
40. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.
Gilbert JW; Wolpin B; Clancy T; Wang J; Mamon H; Shinagare AB; Jagannathan J; Rosenthal M
Ann Oncol; 2017 Sep; 28(9):2067-2076. PubMed ID: 28407088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
